Dr. Stephanie M. Wong
Academic title(s):
- Breast Surgical Oncologist, Jewish General Hospital
- Principal Investigator, Lady Davis Institute For Medical Research
- Associate Professor, Departments of Surgery and Oncology, 91黑料网
- Member, Division of Cancer Prevention, Department of Oncology
Biography:
Stephanie M. Wong, MD, MPH is an assistant professor of surgery at 91黑料网 Medical School and a breast surgical oncologist at the JGH Segal Cancer Centre in Montreal, Canada. She received her medical degree and completed general surgery residency at 91黑料网, her MPH at the Harvard School of Public Health, and in 2019, completed a breast surgical oncology fellowship at Dana-Farber/Brigham and Women鈥檚 Cancer Centre and Massachusetts General Hospital. Her clinical and research interests focus on surgical outcomes following neoadjuvant treatment and high-risk patient populations. She directs the High Risk Breast Clinic at the JGH Stroll Cancer Prevention Centre. In 2021, she was the recipient of the FRQS Chercheurs Boursiers Cliniciens award for research on Optimizing Surgical Decision Making and Prevention Strategies for Women at Elevated Breast Cancer Risk.
Location:
Jewish General Hospital
Department:
Oncology
Surgery
Degree(s):
MD, 91黑料网 School of Medicine, 91黑料网
MPH (Clinical Effectiveness), Harvard School of Public Health, Harvard University
Areas of expertise:
Breast cancer; Hereditary breast cancer; Screening and prevention in women at elevated breast cancer risk
Link(s):
Hospital title:
Breast Surgical Oncologist, Segal Cancer Centre, Jewish General Hospital
Director, High Risk Breast Clinic, Stroll Family Cancer Prevention Centre, Jewish General Hospital
Division:
General Surgery
Surgical and Interventional Sciences
Cancer Prevention
Research areas:
Surgical Outcomes and Quality
Surgical Oncology
Awards, honours, and fellowships:
-
FRQS Clinical Research Scholars Junior 1 Award (2021-2025)
-
QBCF Emerging Scientist Award (2022)
Selected publications:
Current research:
Dr. Stephanie M. Wong鈥檚 laboratory explores clinical outcomes and prevention strategies for women at increased breast cancer risk. Her research focuses primarily on patients with inherited susceptibility due to germline pathogenic variants in BRCA1/2, PALB2, ATM, CHEK2 and other genes, as well as those with a history of atypical breast biopsies or a personal history of chest wall radiation therapy in adolescence and young adulthood. For these high risk groups, her research explores uptake and decision making around endocrine prevention and risk reducing mastectomy. She is also involved in initiatives around mainstream genetic testing for patients with newly diagnosed breast cancer.
Graduate supervision:
Currently supervising students, not accepting new prospective students for 2025-2026
Not Currently Recruiting for 2025-2026:
- Medical Students
- Residents
- Fellows
- M.Sc. Students
- M.Sc. Non-Thesis projects
- Ph.D Students
Areas of interest:
Clinical epidemiology; Research with large population-level databases; Cancer prevention in high-risk patient populations; Surgical decision making
Clinical Interests:
Breast cancer;聽Hereditary breast cancer;聽Screening and prevention in women at elevated breast cancer risk;聽Endocrine prevention
